Stephens & Co. Initiates Boston Scientific With Overweight

Analysts at Stephens & Co. initiated coverage on

with a Overweight rating. The target price for Boston Scientific is set to $21. Boston Scientific shares have gained 35.00 percent over the past 52 weeks, while the S&P 500 index has surged 5.35 percent in the same period. Boston Scientific shares fell 0.34 percent to $17.49 in after-hours trading.